Family investigation
On the basis of the family details provided, 39 members of his family from 4 generations, ranging from 1 to 77 years of age, were invited by letter to attend as outpatients to be screened for Marfan syndrome. Thirty eight members of the family attended and consented to be screened, all had a clinical examination and echocardiograms performed. Each patient was then referred to the ophthalmologists and reviewed after their ocular examination. 11 14 was not invited to the screening clinic as she lives abroad, III 16 was invited but did not attend.
A family pedigree ( Figure 1 ) was constructed from information provided by the family, from case notes and from the death certificates of deceased members which were examined and assessed.
Results
Two deceased members (I 4, II 7), recognized to be at 50% risk of being affected, died from aortic aneurysm dissections which can be taken to indicate the presence of Marfan syndrome in these individuals. The death certificate of another member of the family (II 11) states she died, aged 34, from asphyxia gecondary to an epileptic seizure. One of her children has Marfan syndrome indicating that the deceased patient was an obligate carrier of the gene. The diagnosis of Marfan syndrome in the living members of this family was based on the criteria suggested by Pyeritz and McKusick.' After completion of the screening, 12 living members of this family were diagnosed as having definite Marfan syndrome. This group comprised the propositus, one of his sons, 9 newly diagnosed adults and one newly diagnosed child.
The clinical features of the 11 adults with definite Marfan syndrome are given in This family had no individuals with certain ocular involvement; the reported incidence of lens subluxation is betwben 50-80%.' Marfan syndrome families with no ocular manifestations have previously been reported.5`7 Ogilvie5 described two families with no ocular involvement which had 2 and 3 affected members. Francomano6 reported that 5 out of 12 families studied had no ocular features but the numbers of affected members per family is not mentioned. Boileau7 reported a large family with 19 affected members none ofwhom had ocular involvement. As the incidence of ocular involvement is 50-80%, the absence of ocular features in some Marfan syndrome families will occur by chance alone. However, in large families the absence of ocular features is more likely to be significant.
The lack of ocular involvement in the family described in this report is important for 2 main reasons. Firstly, it raises the possibility that this family may have a genetic mutation which does not manifest the ocular complications of Marfan syndrome. The variability of the Marfan syndrome phenotype may result from heterogeneous underlying genetic defects. Families with no ocular involvement may therefore represent one particular genetic subset of Marfan syndrome patients. Thus, the term Marfan syndrome may encompass several distinct genetic entities and therefore genetic advice to an individual should take into account the particular pattern of disease within that family and not assume Marfan syndrome is a single disease. Secondly, the lack of eye involvement throughout this family removes one of the four diagnostic criteria suggested by Pyeritz and McKusick,' the diagnosis then depends on the presence or absence of cardiac and/or skeletal features.
As a result of screening this family, three groups of patients were identified. Those who clearly had Marfan syndrome, those who did not, and those in whom the diagnosis could not definitely be excluded. The group in whom the diagnosis was unclear were the most difficult to advise and manage. All the patients in this group knew of the morbidity and mortality ofthis disease; they had all consented to being screened as they felt it was in their interest to know their own diagnosis. However, after the screening we were unable to give these 4 adult patients and one child a definite diagnosis. In 3 ofthe cases the patients were middle aged females with normal echocardiograms and thus are unlikely to develop any serious cardiac complications of Marfan syndrome. These 3 patients are all post-menopausal and thus did not need genetic counselling. However, the fourth adult patient in this group was a 21 year old male with some of the skeletal features, a normal echocardiogram and, as with the rest of the family, no ocular signs. Marfan syndrome cannot definitely be excluded, so he will require follow-up with regular echocardiograms to detect the development of any potential cardiac complications. This patient will be reassessed at a later date in an attempt to determine if any signs have developed or changed in the hope we can be more definite about the diagnosis.
This report demonstrates the importance of screening all relatives of a patient with Marfan syndrome as this led to the discovery of9 new adult cases and one child with Marfan syndrome. It has been possible to initiate therapy in this group in an attempt to prevent the major cardiac complication of aortic dissection. In addition to the beneficial effects ofmedical therapy, there are negative effects associated with the diagnosis of Marfan syndrome which may be difficult for a patient with a definite diagnosis to accept. These negative effects, which may be financial, psychological or social, should be taken into account when screening is initiated. This report also illustrates that family screening for Marfan syndrome may detect individuals in whom the diagnosis is unclear and therefore, prior to screening, patients should be informed that a clear diagnosis may not be reached. For the group with an unclear diagnosis, the uncertainty created by the screening is very confusing. The lack of ocular complications in this family is unusual and may have contributed to the difficulty of diagnosis in some cases as ocular involvement is one of the four cardinal features on which the diagnosis is usually based. The need for a reliable laboratory test to aid the diagnosis of Marfan syndrome is clear. Kainulainen et al. have recently mapped a gene causing Marfan syndrome to chromosome 15 which may be the first step in identifying the gene and hence lead to the development of a diagnostic test.8
